Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001023024-26-000014
Filing Date
2026-02-27
Accepted
2026-02-27 06:59:42
Documents
123
Period of Report
2025-12-31

Document Format Files

Seq Description Document Type Size
1 10-K anip-20251231.htm   iXBRL 10-K 2907994
2 EX-4.1 exhibit41.htm EX-4.1 31380
3 EX-21 anip-20251231xexx21.htm EX-21 7709
4 EX-23.1 anip-2025x1231xexx231.htm EX-23.1 2829
5 EX-31.1 anip-20251231xexx311.htm EX-31.1 10036
6 EX-31.2 anip-20251231xexx312.htm EX-31.2 10063
7 EX-32.1 anip-20251231xexx321.htm EX-32.1 7400
13 GRAPHIC anip-20251231_g1.jpg GRAPHIC 408350
  Complete submission text file 0001023024-26-000014.txt   16950076

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT anip-20251231.xsd EX-101.SCH 101159
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT anip-20251231_cal.xml EX-101.CAL 168821
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT anip-20251231_def.xml EX-101.DEF 723957
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT anip-20251231_lab.xml EX-101.LAB 1306990
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT anip-20251231_pre.xml EX-101.PRE 1004510
126 EXTRACTED XBRL INSTANCE DOCUMENT anip-20251231_htm.xml XML 2346368
Mailing Address 210 MAIN STREET WEST BAUDETTE MN 56623
Business Address 210 MAIN STREET WEST BAUDETTE MN 56623 2186343500
ANI PHARMACEUTICALS INC (Filer) CIK: 0001023024 (see all company filings)

EIN.: 582301143 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-31812 | Film No.: 26692504
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)